Form 4: Atara Biotherapeutics CEO AnhCo Nguyen Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Atara Biotherapeutics' CEO, AnhCo Nguyen, sold 3,331 shares of common stock on March 3, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 3, 2025, AnhCo Nguyen, the President and CEO of Atara Biotherapeutics, sold 3,331 shares of the company's common stock.
- The shares were sold at a price of $6.997 per share.
- The sale was executed automatically to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units.
- Following the transaction, Nguyen directly owns 74,123 shares of Atara Biotherapeutics common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder perception, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the stock sale transaction. |
| 03/05/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.